Feed Top Reports Pricing

⌘K

16:10:35·23d

SECFiling

SEC Form 10-K filed by Kairos Pharma Ltd.

KAPA· Kairos Pharma Ltd.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

KAPA
Kairos Pharma Ltd.
Health Care

Related

PR8d
Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
SEC22d
SEC Form 424B3 filed by Kairos Pharma Ltd.
SEC22d
SEC Form 424B3 filed by Kairos Pharma Ltd.
SEC52d
Kairos Pharma Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
PR52d
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
SEC56d
Kairos Pharma Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
PR56d
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
SEC88d
SEC Form EFFECT filed by Kairos Pharma Ltd.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022